commitment
to
health
We bring together distinguished innovators and leaders across clinical health, health management and data science, utilizing new technology and methodologies to dramatically reduce health care costs and improve clinical outcomes.
Leadership
Founders
Board members
Advisory board
Linda T. Hand
CEO
Niall O’Cathasaigh
CFO
Sri Gopalsamy
CTO
Ryan Tarzy
CCO
Lu Lu
Head of Product
Brian Maples, MS, PhD
Vice President, Data Science
Jason Bae, MD
Medical Director
Linda T. Hand
CEO
Linda brings 35 years’ experience to her role as CEO, with an emphasis in organizational leadership, product development, solutions delivery and go-to-market strategies across a diverse portfolio of industries. She has additionally provided management consulting services to several emerging enterprises and venture capital firms.
Before joining Prealize, Linda led the Clinical Trial Optimization Solutions division at IQVIA, where she was responsible for creating and delivering a suite of innovative clinical technology products, fueled by predictive analytics and machine learning algorithms, to drug development organizations worldwide.
Linda is a past President and CEO of the San Francisco-based DecisionView, the leading provider of clinical trial enrollment optimization solutions. She also ran product development and delivery at a number of leading software companies, including DigitalThink, Hyperion, Arbor Software and Sybase.
Linda holds a BA in Computer Science from the University of California, Berkeley, and completed the Haas School of Business Executive Program.
Niall O’Cathasaigh
CFO
As CFO, Niall O’Cathasaigh is the senior executive responsible for sound fiscal management of all financial operations and human resource activities, as well as overseeing capital raising efforts and financial reporting for board and other stakeholder communications.
Niall has been working as a founder and consultant with startups and growth stage companies in the US, Europe and Africa for over 20 years. He works with Countsy, an innovative professional services firm that specializes in working with venture funded startups to provide end to end strategic and back office services. His experience includes work with over 30 startups in the Bay Area, with a focus on healthcare companies, providing financial transparency and strategic guidance as well as enabling funding rounds and acquisitions.
Niall is also a founder and partner of ManoCap, a private equity fund management company that makes equity investments in small to mid-cap enterprises in West Africa. Prior to that he worked at Apple’s European divisions in Ireland and France.
Niall is a qualified financial professional (CIMA). He holds a postgraduate degree in business from University College Dublin, and a joint BA in History and Classical Civilization from University College Galway and Universite De Poitiers.
Sri Gopalsamy
CTO
Sri Gopalsamy is responsible for company’s technical direction, deliver features to build out Prealize’s product eco system, develop a system-level approach for keeping its ML models current, and scale infrastructure to handle massive amounts of healthcare data to be analyzed in real time. He leads engineering and data science teams to build a scalable data platform and sophisticated ML algorithms to deliver market-leading product features to transform healthcare from reactive to proactive.
Prior to joining Prealize, Sri was with Enlighted, where he led engineering and product teams to develop real-time location service SaaS product for healthcare vertical. Enlighted was successfully acquired by Siemens in 2018 to integrate with its large healthcare business. Prior to that, he held VP of Engineering and Data Science role at an ad-tech startup company PubMatic with petabyte scale data volume, and more than 40 billion ad impressions per day.
He spent many years at Walmart eCommerce in variety of engineering leadership roles and helped grow the company from $70M to over $2B in revenue. While there, he led teams to launch new eCommerce businesses in China and Canada.
Sri holds MS degree in Operations Research.
Ryan Tarzy
CCO
As chief commercial officer of Prealize, Ryan Tarzy is responsible for all commercial activities, including sales, customer success, implementation and marketing.
Prior to joining Prealize, Tarzy was with CoverMyMeds, which was acquired by McKesson in 2017 for $1.2 billion, one of the largest exits in the history of digital health. While there, he served in a variety of roles including vice president of Strategy and Business Development and director of the Incubation Studio, where he led a cross-functional team taking new products to the provider market. Most recently, he served as vice president of Sales and Customer Success, leading the commercial side of the provider vertical at CoverMyMeds.
Previously, he served as senior vice president of Business Development for PokitDok and vice president of Business Development at Healthline Networks.
Tarzy also cofounded two companies – MediKeeper, one of the early pioneers in digital health, and Playful Bee, an early childhood development startup with the mission of delivering children to Kindergarten healthy and prepared for school.
A graduate of Northwestern University, Tarzy earned a bachelor’s degree in Mathematical Methods in the Social Sciences, and Economics.
Lu Lu
Head of Product
As Head of Product at Prealize,, Lu leads discovery, development, and execution of the product vision, strategy, and roadmap using a customer centered approach across multi-functional product teams. She is passionate about building technology products to address complex challenges in healthcare and working with customers throughout the product development process.
Prior to Prealize, Lu had built 12 years of experience in healthcare across strategy and operations. She drove strategy and business development at Bay Health, a joint venture between UCSF Health and John Muir Health that is committed to redefining care and population health in the San Francisco Bay Area. At The Chartis Group, Lu advised leading health systems and medical groups across the country on clinical operations transformation, strategic planning, and how they intersect on the journey towards value. Lu’s experience also includes research in health policy and pediatric behavioral health.
Lu received her Masters in Health Policy and Management from Harvard School of Public health and Bachelors in Psychology from the University of California, Los Angeles.
Brian Maples, MS, PhD
Vice President, Data Science
Brian Maples leads the company’s development and execution of cutting edge machine learning methods applied to large and diverse member data sets. His work yields precise identification of members who are most at risk for as yet unidentified future high cost events.
Prior to joining Prealize, Brian was a Data Scientist at Nuna Health, where he designed and developed machine learning and analytics products and capabilities in the healthcare space. He has also been the lead inventor at Ionian Technologies, a diagnostics startup that was subsequently acquired by Alere. While a PhD student at Stanford, Brian developed a machine learning method for large medical genetics data sets that is currently being privately licensed.
Brian received both his PhD in Biomedical Informatics and MS in Statistics from Stanford University, and a BA in Science and Management from Claremont McKenna College.
Jason Bae, MD
Medical Director
As the Medical Director, Jason is responsible for ensuring that Prealize’s solutions are evidence-based and of the highest clinical rigor.
Prior to Prealize, Jason had accumulated years of experience in clinical medicine, digital health, population health, and value-based care. Jason was at CareMore Health where he led its virtual care program and its Medicare Advantage market in the Santa Clara County. He also served as the program director at Last Mile Health, a non-profit organization renowned for its innovative health care delivery model, as well as a consultant with the Boston Consulting Group.
Jason is a board-certified internist and practices outpatient medicine at Palo Alto Medical Foundation. He received his MD from Yale, and his BA and MBA from Harvard, latter of which was supported by Paul and Daisy Soros Fellowship. Jason completed his internal medicine residency at Massachusetts General Hospital/Harvard Medical School.
Nigam Shah, MBBS, PhD
Co-Founder
Arnold Milstein, MD, MPH
Co-Founder
Nigam Shah, MBBS, PhD
Co-Founder
Dr. Shah’s research focuses on combining machine learning and prior knowledge in medical ontologies to enable the learning health system.
Dr. Shah is Associate Professor of Medicine (Biomedical Informatics) at Stanford University, Medical Director, Research Informatics, Stanford Health Care, Co-Chair for Analytics, Center for Population Health Sciences, Stanford and a member of the executive committee of the Biomedical Informatics Graduate Program, which trains future research leaders to design and implement novel quantitative and computational methods to solve challenging problems across the entire spectrum of biology and medicine.
He is also the Assistant Director of the Center for Biomedical Informatics Research at Stanford, dedicated to advancing the state of the art in semantic technology, biostatistics, and the modeling of biomedical systems to benefit clinical and translational research as well as patient care.
Dr. Shah received the AMIA New Investigator Award for 2013 and the Stanford Biosciences Faculty Teaching Award for outstanding teaching in his graduate class on “Data Driven Medicine.”
Dr. Shah holds an MBBS from Baroda Medical College, India, a PhD from Penn State University and completed postdoctoral training at Stanford University.
Associate Professor of Medicine, and Biomedical Data Science, Stanford University
Associate Professor of Medicine, and Biomedical Data Science, Stanford University
Arnold Milstein, MD, MPH
Co-Founder
Dr. Milstein is nationally recognized for his leadership in discovering less costly paths to high quality health care across large populations. He is a Professor of Medicine at Stanford and directs the University’s Clinical Excellence Research Center. The Center is a collaboration of the Schools of Medicine and Engineering to design and demonstrate in multi-state locations new health care delivery models that safely lower per capita health care spending and improve patients’ experience of healthcare.
Before joining Stanford, Dr. Milstein’s career of applied research spanned private and public sector healthcare delivery and purchasing strategy. After launching a healthcare performance improvement firm subsequently acquired by Mercer and expanded globally, he co-founded two nationally influential public benefit initiatives, the Leapfrog Group and the Consumer Purchaser Alliance.
Dr. Milstein served on the faculty of UCSF’s Health Policy Institute and was appointed to a six year term as a Congressional MedPAC Commissioner. Since its inception, he has been the Medical Director of the Pacific Business Group on Health, the largest employer-led regional healthcare value improvement coalition in the U.S. Citing his nationally distinguished innovation in health care policy and healthcare delivery, Dr. Milstein was selected for the highest annual award by both the National Business Group on Health and of the American College of Medical Quality.
Elected to the National Academy of Medicine, Dr. Milstein received a BA in Economics at Harvard, MD at Tufts, and an MPH in Healthcare Evaluation at UC Berkeley.
Profess of Medicine, Stanford
Director Clinical Excellence Research Center, Stanford University
Member, National Academy of Medicine
Thomas McKinley, MS, MBA
Linda T. Hand
Kent Marquardt
Mark D. Smith, MD, MBA
Elizabeth Spaulding
Nigam Shah, MBBS, PhD
John Doerr
Thomas McKinley, MS, MBA
Thomas McKinley has a track record of helping entrepreneurs create significant and successful enterprises. His focus, along with his partners at Cardinal Partners, has been to identify early new market opportunities in health care and work with entrepreneurs, scientists, clinicians, engineers and inventors to grow great companies from great ideas. The result has helped improve the lives of millions, while also rewarding investors with extraordinary returns. Since 1997, companies funded by Cardinal have a cumulative market valuation exceeding $6 Billion.
Thomas is the Chairman of the Board of Prealize and West Coast Representative for Cardinal Partners. Prior to joining Cardinal, Thomas was the Co-Founder and Co-Managing Partner of Partech International. His investments include Ascend Communications (ASND acquired by Lucent Technologies), Automated Healthcare (acquired by McKesson), Medicode (acquired by United Healthcare) and VISICU (EICU acquired by Philips). He is currently on the boards of lifeIMAGE, a cloud-based medical imaging sharing platform for hospitals, physicians, and patients; and Teladoc (public), a telehealth services providing doctor consults to consumer.
Thomas has also served on several other boards and is a member of the Health Management Academy, and a founding member of Healthcare IT Advisory Group to the State of California.
Thomas received his BS in Economics from Harvard University, an MS in Accounting from New York University and his MBA from Stanford Graduate School of Business.
Partner, Cardinal Partners
CEO, Prealize
Linda T. Hand
Linda brings 35 years’ experience to her role as CEO, with an emphasis in organizational leadership, product development, solutions delivery and go-to-market strategies across a diverse portfolio of industries. She has additionally provided management consulting services to several emerging enterprises and venture capital firms.
Before joining Prealize, Linda led the Clinical Trial Optimization Solutions division at IQVIA, where she was responsible for creating and delivering a suite of innovative clinical technology products, fueled by predictive analytics and machine learning algorithms, to drug development organizations worldwide.
Linda is a past President and CEO of the San Francisco-based DecisionView, the leading provider of clinical trial enrollment optimization solutions. She also ran product development and delivery at a number of leading software companies, including DigitalThink, Hyperion, Arbor Software and Sybase.
Linda holds a BA in Computer Science from the University of California, Berkeley, and completed the Haas School of Business Executive Program.
CEO, Prealize
Kent Marquardt
A healthcare management executive with broad and deep experience, Kent Marquardt is today the CEO of Maverick Advisors, LLC which specializes in innovation and strategy with healthcare companies using analytics and customer engagement to attack inefficiencies in healthcare costs.
Kent has been Executive Vice President and Chief Financial Officer at Premera Blue Cross where he was responsible for the Premera family of companies finance, actuarial, corporate informatics, underwriting, and healthcare economics departments. He also had responsibility for the Innovation Program and Strategic Investments and was part of the Executive Leadership Team that drove overall strategy and long-term direction.
Prior to Premera, Kent was CEO of American Dental Specialist Inc., and COO as well as CFO of western operations of MedPartners, Inc., the nation’s largest publicly held physician practice management company. He is also the former CFO for PriMed Management Consulting, Inc. (Hill Physicians management company).
Kent Marquardt was formerly with KPMG Peat Marwick and a partner in the Los Angeles and Phoenix offices.
Kent holds a MA in business administration from the University of Wisconsin where he also earned his BA.
CEO, Maverick Advisors
Mark D. Smith, MD, MBA
Dr. Mark Smith is a nationally-recognized health policy expert who has consulted for the governments of Kuwait, Denmark, and Singapore, and is a frequent keynote speaker, including for Microsoft, Health 2.0, Kaiser Permanente, and the Library of Congress. Dr. Smith was elected to the Institute of Medicine where he chaired the IOM’s Committee on the Learning Healthcare System, which produced the widely-publicized 2012 report “Best Care at Lower Cost.” He was also a Menschel Senior Policy Fellow at the Harvard School of Public Health.
Mark Smith is currently a Professor of Clinical Medicine at the University of California at San Francisco and Visiting Professor at the School of Public Health at the University of California at Berkeley. He is formerly the Founding President of the California HealthCare Foundation, which he led from its formation into a recognized leader in delivery system innovation, public reporting of care quality, and applications of new technology in health care, with a current corpus of approximately $720 million.
Dr. Smith was also the Executive Vice-President of the Henry J. Kaiser Family Foundation, where he oversaw programs in HIV, Reproductive Health, and the Health Care Marketplace. Prior to that, he was on the faculty at the Johns Hopkins Schools of Medicine and of Public Health, and directed the AIDS clinic there.
Dr. Smith is widely published, serves on several Boards and advises several startup companies and venture funds. He has been honored by the California Legislature, the California Hospital Association, Grantmakers in Health, the Society of General Internal Medicine, and others.
Dr. Smith holds a BA from Harvard College, an MD from the University of North Carolina, and an MBA from the Wharton School at the University of Pennsylvania. A Board-certified internist, he maintains an active clinical practice in HIV care at Zuckerberg San Francisco General Hospital.
Professor, Clinical Medicine, University of California, San Francisco
Elizabeth Spaulding
Elizabeth Spaulding is the head of Bain & Company’s global Digital practice. She has significant experience with both public and private equity owned businesses and advises clients on a range of issues related to digital disruption, including the reinvention of the customer experience, marketing, innovation in operations including automation and predictive analytics, as well as helping develop new products and services.
A highly sought-after expert on digital transformations, as well as new and emerging trends, Elizabeth’s perspectives have been quoted and published by national and international business media, including Forbes, The Wall Street Journal, The New York Times, USA Today, Business of Fashion, The Los Angeles Times, and Harvard Business Review.
At Bain, Elizabeth supports clients in digital transformations. She founded and leads ADAPT – the firm’s technical team of digital experts (Advanced Digital and Product Team) that work hand in hand with consulting case teams which includes S/W engineering, user design and prototyping, innovation and design thinking, and marketing analytics.
She also builds connections between clients and digital leaders to help develop the capabilities needed to win in a digital economy. She created the Bain Innovation Exchange that connects clients with venture capitalists, startups, and major tech platforms. Examples of these relationships include the Stanford d.school, Facebook, CrunchBase, and various venture capitalists and their portfolio companies.
Elizabeth received her MBA, as an Arjay Miller Scholar, from the Stanford Graduate School of Business and a BAS in industrial engineering and French from Stanford University.
Partner, Global Head of Bain & Company’s Digital Practice
Nigam Shah, MBBS, PhD
Dr. Shah’s research focuses on combining machine learning and prior knowledge in medical ontologies to enable the learning health system.
Dr. Shah is Associate Professor of Medicine (Biomedical Informatics) at Stanford University, Medical Director, Research Informatics, Stanford Health Care, Co-Chair for Analytics, Center for Population Health Sciences, Stanford and a member of the executive committee of the Biomedical Informatics Graduate Program, which trains future research leaders to design and implement novel quantitative and computational methods to solve challenging problems across the entire spectrum of biology and medicine.
He is also the Assistant Director of the Center for Biomedical Informatics Research at Stanford, dedicated to advancing the state of the art in semantic technology, biostatistics, and the modeling of biomedical systems to benefit clinical and translational research as well as patient care.
Dr. Shah received the AMIA New Investigator Award for 2013 and the Stanford Biosciences Faculty Teaching Award for outstanding teaching in his graduate class on “Data Driven Medicine.”
Dr. Shah holds an MBBS from Baroda Medical College, India, a PhD from Penn State University and completed postdoctoral training at Stanford University.
Co-Founder
John Doerr
John is an engineer, acclaimed venture capitalist, and the chairman of Kleiner Perkins. For more than 38 years, John has served entrepreneurs with ingenuity and optimism, bringing ideas worth spreading to disruptive leaders and teams.
John was an original investor and board member at Google and Amazon, helping to create over 650,000 jobs and the world’s second and third most valuable companies. He’s passionate about helping entrepreneurs reimagine the future, from health care transformation to machine learning.
John serves on the boards of Alphabet/Google, Amyris and Bloom Energy, as well as private ventures including health care leaders Lumeris and Nuna.
Outside of Kleiner Perkins, John works with social entrepreneurs for change in public education, the climate crisis, and global poverty. These include the Climate Reality Project and ONE.org. He serves on the board of the Obama Foundation
John earned degrees in electrical engineering from Rice University and business from Harvard and is a member of the American Academy of Arts and Sciences.
Chairman, Kleiner Perkins
Susan Athey, PhD
Advisor
Jeffrey Bailet, MD, MSPH
Advisor
Ray Bradford, MBA
Advisor
Colt Courtright
Advisor
John Espinola, MD, MPH, MBA
Advisor
David Fields
Advisor
Alan Glaseroff, MD
Advisor
Trevor Hastie, PhD
Advisor
Ken Paulus, MA
Advisor
Ronald A. Paulus, MD
Advisor
Lee Sacks, MD
Advisor
Kevin A. Schulman, MD, MBA
Advisor
Juan Chaluja
Advisor
Chris DeRienzo, MD
Advisor
Kristin Torres Mowat
Advisor
Susan Athey, PhD
Advisor
A member of the National Academy of Science and the American Academy of Arts and Sciences, Dr. Susan Athey received the John Bates Clark Medal, awarded by the American Economic Association to “that American economist under the age of forty who is adjudged to have made the most significant contribution to economic thought and knowledge.”Susan Athey is the Economics of Technology Professor at Stanford Graduate School of Business. Her research and teaching cover the economics of the internet and digital marketplaces, marketplace design, platform businesses, online advertising, the news media, financial technology, big data, machine learning, and statistical methods for causal inference. She previously taught at the economics departments at MIT, Stanford and Harvard.
Professor Athey also advises governments and businesses on marketplace design, platform strategy, big data, and financial technology. She serves on several boards including Expedia, and is an advisor to early stage venture capital funds.
Dr. Athey received her BA from Duke University in economics, computer science, and mathematics and her PhD. in economics from Stanford. She also holds an honorary doctorate from Duke University.
Economics of Technology Professor, Stanford Graduate School of Business
Jeffrey Bailet, MD, MSPH
Advisor
With over 20 years of health care experience, Dr. Jeffrey Bailet is currently Executive Vice President of Health Care Quality and Affordability at Blue Shield of California, a 4-million-member nonprofit health plan that serves the state’s commercial, individual and government markets.
In his role at Blue Shield of California, Dr Bailet is responsible for the management and performance of company’s Network Management, Health Care Services and Wellvolution® teams. He is currently chair of the executive committee of AMGA (formerly the American Medical Group Association).
Prior to joining Blue Shield, Dr.Bailet served as Executive Vice President at Aurora Health Care and President of Aurora Health Medical Group, which includes 1,800 physicians and 900 advance practice clinicians across 180 clinics and 15 hospitals in Wisconsin and northern Illinois. Dr. Bailet was recently appointed to the Government Accountability Office’s new Physician-Focused Payment Model Technical Advisory Committee and currently serves on the Board of the Wisconsin Medical Society. He is also a member of the Group Practice Advisory Committee of the American Medical Association.
Dr Bailet is a board-certified otolaryngologist, a Fellow of the American Academy of Otolaryngology and the American College of Surgeons.
He is a graduate of the University of Washington School of Medicine, and completed his residency in Otolaryngology Head and Neck Surgery at UCLA Medical Center. He also holds a M.S.P.H. in Environmental Health from the University of Washington School of Public Health and Community Medicine.
Executive VP of Health Care Quality and Affordability, Blue Shield of California
Ray Bradford, MBA
Advisor
Ray Bradford is a member of the Stanford Medicine Board of Fellows, a past Forbes 30 under 30 designee, and named inventor on multiple patent applications related to scalable data systems.
Ray Bradford is founder and CEO of Spruce Health, dedicated to tackling the challenge of making high-quality healthcare more accessible, scalable, and consumer-friendly with the help of software.
Prior to founding Spruce, Ray was a Partner at Kleiner Perkins Caufield & Byers focused on early-stage technology investments for the firm’s digital practice. He was also an early product development executive at Amazon Web Services, where he helped grow the company’s cloud infrastructure business. At Amazon, he was responsible for developing multiple new big data services including Amazon Redshift, and led one of the core product management teams, responsible for the definition, launch, and business growth of many other new database services, including Amazon Relational Database Services (RDS), Amazon ElastiCache, and Amazon DynamoDB.
Ray received his MBA from Stanford Business School, where he was an Arjay Miller Scholar.
Founder and CEO, Spruce Health
Colt Courtright
Advisor
Colt Courtright leads Corporate Data & Analytics at Premera Blue Cross, where he is responsible for strategies that impact its 2.1 million members, 38,000 physician network, and self-insured employers such as Amazon, Microsoft, Starbucks, Expedia, Weyerhaeuser and other household name companies.
Colt brings over 20 years’ experience performing new product innovation, supporting strategic partnerships, and overseeing advanced analytics and data management solutions. Recently this has included initial product deployments for companies such as Landmark, MOBE, Quartet, Vim/BookMD, Collective Medical Technologies, and Prealize. Colt has direct responsibility for real-time EMR clinical data exchange, data warehouse, data lake, data science, and business intelligence production environments, along with sales, marketing, clinical, and operational analytic and reporting teams.
Prior to joining Premera, Colt was Senior Medical Economist for Science Applications International Corporation (SAIC), where he led international studies in clinical care, cost and utilization, and oversaw evaluations of data management solutions including the $400 million Military Healthcare System data warehouse. Colt has been Senior Scientist for a national physician practice management organization, and co-founder of two start-up companies delivering analytic products and consulting services to Cedars-Sinai, AMGA, Mutual of Omaha, CareOregon Medicaid, and other prominent healthcare organizations.
Colt completed his undergraduate degree in Economics at the University of Essex and earned a Master in Public Administration at Lewis & Clark College in Oregon.
Director, Corporate Data & Analytics, Premera Blue Cross
John Espinola, MD, MPH, MBA
Advisor
As Executive Vice President of Healthcare Services for Premera Blue Cross, John Espinola, is responsible for Premera’s healthcare strategy, corporate innovation and strategic investments. He leads Premera’s efforts to deliver healthcare value to customers.
Dr. Espinola leads both Premera’s collaboration with healthcare providers and other partners, and Premera’s innovation and strategic investments efforts.
In addition to his work at Premera, Dr Espinola has served in various leadership roles at other health plans including as an Executive Director at United Healthcare. He has also practiced geriatric medicine in the Seattle metro area in a variety of settings.
Dr. Espinola is board certified in geriatrics and internal medicine. He trained in internal medicine at Scripps Clinic in San Diego and in geriatrics at Harborview Medical Center in Seattle. He earned his MD and MPH from Tufts University School of Medicine, a MBA from the University of Washington, and BA from the College of the Holy Cross.
Executive VP of Healthcare Services, Premera Blue Cross
David Fields
Advisor
David Fields has more than 30 years health plan experience and presently serves as President for Dean Health Plan, a 400,000+ member health plan serving Commercial, Individual and Government markets. Dean Health Plan is also the sole insurance subsidiary for SSM Health and a key part of its growth strategy. Prior to joining Dean Health Plan, David served as Executive Vice President – Markets for Blue Shield of California where he was responsible for management and performance for all lines of business representing $20 billion in annual revenue.
David has also been a senior officer at Aetna, leading the Mid-America Region, and spent more than ten years with Anthem Blue Cross Blue Shield. He started his health care career at Humana and was a CPA.
Fields earned a bachelor’s degree in Commerce from the University of Louisville.
President, Dean Health Plan
Alan Glaseroff, MD
Advisor
Dr. Glaseroff is a national leader in preventing costly health crises. He is faculty at Stanford’s Clinical Excellence Research Center, Adjunct Professor of Medicine and Co- Founder, Stanford Coordinated Care, for patients with complex chronic illness. He also currently serves as national faculty for the Institute of Healthcare Improvement’s “Better Care, Lower Cost” collaborative.
Dr. Alan Glaseroff works with Dr. Arnie Milstein at Stanford’s Clinical Excellence Research Center to help develop new models of care. He has also served as the Director of Workforce Transformation in Primary Care at Stanford where he was responsible for training the teams for Primary Care 2.0, a radical redesign of primary care. He formerly served as Co-Director of Stanford Coordinated Care, a service for patients with complex chronic illness.
Dr. Glaseroff, a member of the Innovation Brain Trust for the UniteHERE Health, currently serves as faculty for the Institute of Healthcare Improvement’s “Better Care, Lower Cost” collaborative. Dr. Glaseroff was named the “California Family Physician of the Year” for 2009. His focus is on the intersection of the meaning of patient-centered team care, patient activation, and the key role of self-management within the context of chronic conditions.
He received his MD from Case Western Reserve.
Faculty, Stanford University’s Clinical Excellence Research Center
Trevor Hastie, PhD
Advisor
Dr. Trevor Hastie is the John A. Overdeck Professor of Mathematical Sciences at Stanford University, and is a member of the US National Academy of Science. He is known for his contributions to applied statistics, especially in the field of machine learning, data mining, and bioinformatics.
Dr. Hastie has authored five books, including the widely referenced Elements of Statistical Learning: Data Mining, Inference, and Prediction, and published over 180 articles in the field. His current research focuses on applied statistical modeling and prediction problems in biology, genomics, medicine and industry.
Prior to his appointment at Stanford, Dr. Hastie was a part of the statistics and data analysis research group at what was then AT&T Bell Laboratories. He interned at the Biomath department at Oxford University; the London School of Hygiene and Tropical Medicine; and the Johnson Space Center.
Dr. Hastie earned his MS from University of Cape Town in South Africa (where he is from), his BS from Rhodes University, South Africa and PhD from Stanford University. He has been listed as an “ISI Highly Cited Author in Mathematics” by the ISI Web of Knowledge.
The John A. Overdeck Professor of Mathematical Sciences, Stanford University
Ken Paulus, MA
Advisor
Ken Paulus is a transformative leader with more than 30 years’ experience in the health care sector, building strategic partnerships, integrating payment and delivery systems, and implementing consumer-centric health care solutions. As president and CEO of Prime Therapeutics (Prime), Paulus is responsible for the strategic direction and operations of one of the nation’s premier total drug management companies, with more than 28 million members in commercial markets and government programs.
From 2005 to 2015, Paulus held leadership roles at Allina Health; including CEO, president and chief operating officer (COO). Based in Minneapolis, Allina is one of the nation’s largest, most seamlessly integrated health delivery systems. During his tenure, Paulus led Allina beyond traditional acute care and into improving health, home-based care, retail pharmacy, and management of complicated specialty and chronic disease.
Earlier in his career, Paulus served as president and CEO of Harvard Vanguard Medical Associates, the staff model partner of Harvard Pilgrim Healthcare in Boston. While at Harvard Vanguard, Paulus led creation of Atrius Health and served as the system’s first president and CEO. Prior to Atrius, he was COO of Partners Community Healthcare, the risk-bearing entity of Partners Healthcare System.
Most recently, Paulus served as an executive advisor with Water Street Healthcare Partners, a private equity firm focused on the health care sector, giving him yet another perspective on value and value creation. Paulus also serves on several boards of directors, including Breg Inc., and Teladoc Health Inc.
Paulus earned a Bachelor of Arts degree in biological sciences from Augustana College in Rock Island, Illinois., and a Master of Health Care Administration from the University of Minnesota in Minneapolis.
President and CEO, Prime Therapeutics
Ronald A. Paulus, MD
Advisor
Voted one of Modern Healthcare’s Top 50 Most Influential Physician Executives and Leaders, Ronald A. Paulus, MD is President and CEO of Mission Health, a $2 billion integrated safety-net health system serving western North Carolina. He previously served as Executive Vice President, Clinical Operations and Chief Innovation Officer for Geisinger Health System where he managed Geisinger’s hospitals and physician group practice.
During his tenure, at Mission Health, the system has reduced inpatient mortality by more than half, achieved six-sigma medication safety results, improved patient experience to above the 90th percentile and became the only health system ever designated as one of the nation’s Top 15 Health Systems in six of seven years by IBM Watson Health — despite serving a region older, poorer, sicker and less likely to be insured than state and national averages.
Dr. Paulus has numerous peer-reviewed book chapter and journal publications, serves on multiple boards, and speaks regularly on the topics of health care quality and efficiency, innovation, physician and health system leadership and new models of care.
Dr. Paulus received his MD from The School of Medicine, University of Pennsylvania, as well as his MBA in healthcare management, and a BS in Economics from The Wharton School, University of Pennsylvania.
President and CEO, Mission Health
Lee Sacks, MD
Advisor
Over the course of his distinguished career, Dr. Lee Sacks achieved national recognition for his impact on patient safety, health outcomes, and clinical integration and was recognized by Modern Health Care in 2018 as one of the top 50 physician executives. He is the retired Executive Vice President and Chief Medical Officer for Advocate Health Care, the largest health system in Illinois. Dr. Sacks served on the Advocate Health Care executive leadership team since its founding in 1995, and has been affiliated with Advocate and its predecessors, on medical staff and in other roles, for the past 41 years. At Advocate, he was responsible for health outcomes, patient safety, information systems, managed care contracting, PHO operations, research, medical education, risk management and insurance.
Dr. Sacks served as Advocate’s Chief Medical Officer for over 20 years and was the founding CEO of Advocate Health Partners, a clinically integrated network with over 5,000 physicians, coordinating care for approximately 1 million attributable lives in commercial, Medicare and Medicaid populations. He currently serves as faculty for leadership development of physician executives with the Health Management Academy.
Dr. Sacks is a fellow of the Institute of Medicine, Chicago. Prior to the merger that created Advocate, Dr. Sacks served in a variety of executive roles at Lutheran General Health System and practiced family medicine in suburban Chicago.
Dr. Sacks earned his BS at the University of Pennsylvania and MD from the University of Illinois, College of Medicine.
Former CMO, Advocate Aurora Health
Kevin A. Schulman, MD, MBA
Advisor
With 300 original articles, 80 review articles/commentaries, and 40 case studies/book chapters, Kevin Schulman has had an undeniably broad impact on health policy. His peer-reviewed articles have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is a member of the editorial/advisory boards of the American Heart Journal, Health Policy, Management and Innovation, and Senior Associate Editor of Health Services Research.
Dr. Schulman was appointed as Professor of Medicine, Associate Chair of Business Development and Strategy in the Department of Medicine, Director of Industry Partnerships and Education for the Clinical Excellence Research Center at the Stanford University School of Medicine, and, by courtesy, Professor of Economics at Stanford’s Graduate School of Business.His research interests include organizational innovation in health care, health care policy and health economics. Formerly at Duke’s Fuqua School of Business, Dr. Schulman oversaw the growth of the health sector management program, graduating almost 1,500 students. He is the Founding Director of the unique Master of Management in Clinical Informatics program, originally offered through the Fuqua School of Business and now housed in the Duke University School of Medicine. He has served as a Visiting Professor in General Management at Harvard Business School, and a visiting scholar. He is also the Founding President of the Business School Alliance for Health Management, a consortium of the leading business schools offering health management programs.
Dr. Schulman is an elected member of ASCI and AAP. He received his MD from the New York University School of Medicine and his MBA from the Wharton School of the University of Pennsylvania. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania and is Board certified in internal medicine.
Professor of Medicine, Associate Chair, Business Development and Strategy, Director of Industry,Partnerships and Education, Stanford University School of Medicine
Juan Chaluja
Advisor
Juan Chaluja is Florida Blue’s vice president of Commercial Markets Analytics and Business Performance. In this role, Chaluja is responsible for establishing strategic direction to enable industry-leading analytics capabilities to drive business value and provide market insights and intelligence, inform tailored solutions to support customers and improve internal efficiencies. Chaluja also has accountability for organizational effectiveness and business performance across the Commercial Market segments.
Chaluja has more than 25 years of domestic and international experience in the health insurance industry. Prior to joining Florida Blue in 2007, Chaluja held various roles in underwriting, medical informatics, reinsurance, investigation fraud and Medicare risk adjustment. Chaluja began his career in Central America where he served as a statistician, and then moved back to the United States in 1998. Upon his return to the US, he served as a consultant for the Latin American region at Wakely & Associates. Chaluja holds a Bachelor’s degree in mathematics from Columbus State University and has completed executive education programs at UCLA Anderson Graduate School of Management as well as Fellow, Life Management Institute (FLMI) and is currently a Fellow for America’s Health Insurance Plans (AHIP) Executive Leadership Program.
Vice President, Commercial Markets Analytics and Business Performance
Chris DeRienzo, MD
Advisor
Dr. Chris DeRienzo serves as Senior Vice President and System Chief Medical & Quality Officer of WakeMed Health & Hospitals, a nationally recognized, private, not-for-profit, 941-bed health system based in Raleigh, NC. In this role, Chris has senior executive responsibility for quality, safety, clinical transformation, medical staff services and continuous improvement across WakeMed's inpatient, outpatient, ambulatory, and post-acute enterprise.
Recognized by Modern Healthcare in 2018 as one of 15 “Up and Comers” Under 40 and Becker’s as one of healthcare’s “Rising Stars,” Chris has published and presented internationally on leveraging analytics to drive continuous improvement, implementing data science in healthcare, and the intersection of humanity and technology. A frequent keynote speaker and the first ever HIMSS SPARK (TED-style) Speaker, he also advises both state and national governments and companies from early-stage to the Fortune 500 and volunteers as a member of the Mercy Health (Chesterfield, MO) Board Quality Committee and the YMCA Blue Ridge Assembly Board.
Board Certified in both Pediatrics and Neonatology, Dr. DeRienzo completed his M.D., Masters in Public Policy, and post-graduate medical training all at Duke.
Senior Vice President and System Chief Medical & Quality Officer, WakeMed Health & Hospitals
Kristin Torres Mowat
Advisor
Kristin Torres Mowat is an experienced leader in scaling healthcare and technology businesses. She enjoys a successful track record developing and implementing growth strategies in Fortune 500 and high growth startup environments. She excels at inspiring teams to address complex problems, creating and managing alliances, business development and developing talent across business functions.
She most recently served as SVP Corporate Development for Castlight Health. She built and managed the portfolio of medical, pharmacy, dental, and behavioral health plan relationships along with the data operations capabilities. She led Castlight’s efforts to grow through the company’s strategy, strategic partnerships, and inorganic opportunities. Previously, Kristin was vice president at DaVita Inc., a Fortune 500 and one of the largest global healthcare services providers. She was responsible for corporate strategy, started and ran Falcon EHR (electronic health record business), and recruiting for the Redwoods Leadership Development Program.
Kristin earned her bachelors in international relations and minor in human biology from Stanford University. After a consulting career at Bain & Co. and The Bridgespan Group, Kristin worked at Chiron Corporation before returning to Stanford to earn her MBA and JD. She serves as a Director on the board of Women’s Health USA, a leading business partner to women’s healthcare providers. Kristin brings her experience in strategy, corporate development, acquisitions, integrations, and business development across healthcare services and technology sectors to every team with which she works.
Senior Vice President Corporate Development, Castlight Health
Investors
Thought leadership
Predicting Patient Cost Blooms in Denmark
DownloadLatest news
Caring For The Unseen Sufferers Of COVID-19: How Artificial Intelligence Can Enable Proactive Care And Help Avert An Epidemic Of Preventable Diseases
Health IT Outcomes | May 11, 2020
Prealize Wins MedTech Breakthrough Innovation Award for Second Consecutive Year
Press Release | April 29, 2020
Cardinal Analytx Rebrands as Prealize to Reflect Power of Solution to Deliver Proactive Care by Turning Insights into Action
Press Release | January 09, 2020
It’s time for AI-enabled solutions in health care to live up to their buzz
KevinMD | September 24, 2019
Doctor Bot: How artificial intelligence is already changing healthcare, and what’s coming next
GeekWire | September 19, 2019